Feb. 7 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading on Feb. 9. Stock symbols are in parentheses.
Amgen Inc. (AMGN:US): The world’s largest biotechnology company said it gained European approval to sell its new drug, Nplate, for a chronic bleeding disorder.
Boeing Co. (BA:US): The world’s No. 2 commercial-plane maker won a contract valued at as much as $2.95 billion to build 15 C-17 transport aircraft, the Defense Department said on its Web site.
Hartford Financial Services Group Inc. (HIG:US): The insurer that lost $2.75 billion last year may be allowed by its state regulator to reduce reserves in an effort to bolster the company’s finances, according to a person familiar with the matter.
Motorola Inc. (MOT:US): The second-biggest U.S. seller of mobile phones said in a regulatory fling that its co-chief executive officers spent $2.75 million buying 725,000 shares, their first purchases since the price fell 72 percent last year.
Smithfield Foods Inc. (SFD:US): The world’s biggest pork processor said it agreed to pay higher interest rates and pledged a processing plant as collateral to amend its $1.3 billion revolving credit facility.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment